Latest Dermatology News From Medical News Today.

Total news: 276
Last news: May 2, 2008 19:00:00

The Minister for Health and Children, Ms. Mary Harney T.D., proposes to introduce legislation to control the use of sun beds and has launched a public consultation process relating to her proposals. - [Read more]

ZymoGenetics, Inc. (NASDAQ:ZGEN), presented results at the American Burn Association annual meeting from a clinical trial with RECOTHROM™ Thrombin, topical (Recombinant) administered by spray device to burn wound excision sites. The study evaluated the safety and immunogenicity of RECOTHROM for patients undergoing skin grafting for burns. - [Read more]

Until now, Female Hair Loss has been difficult to predict and diagnose. That changes with todays announcement that HairDX, LLC (http://www.hairdx.com), pioneers of consumer-friendly genetic tests for hair loss, has introduced a screening test using genetic markers strongly associated with Female Hair Loss (Female Androgenetic Alopecia). - [Read more]

Actelion Pharmaceuticals UK Ltd announced that Tracleer® (bosentan), a dual endothelin receptor antagonist, has been approved in the UK and Ireland for the reduction of the number of new digital ulcers (DUs) in patients with systemic sclerosis (SSc) and ongoing DU disease.1DUs are a frequent, extremely painful and disabling complication of SSc2, caused by a reduced blood flow to the fingers and toes. - [Read more]

If you are a regular lip balm or lip gloss user you should perhaps bear in mind that there is a good chance your risk of developing skin cancer is greater, according to researcher, Dr. Christine Brown, Baylor University Medical Center, Dallas. The balms/glosses actually attract the ultraviolet rays. Not only do we have to protect our skin from the sun, says Dr. Brown, but also our lips. In fact, one quarter of all Americans do not appear to use any form of lip protection. - [Read more]

Delcath Systems, Inc. (Nasdaq: DCTH) announced that the Institutional Review Board (IRB) of the University of Maryland Medical Center (UMMC) has approved UMMCs participation in the Phase III study of the Companys Percutaneous Hepatic Perfusion (PHP) System for the isolated, high dose delivery of the anti-cancer agent melphalan to treat inoperable metastatic melanoma in the liver. - [Read more]

Aeolus Pharmaceuticals, Inc. (OTC Bulletin Board: AOLS) reported that researchers from National Jewish Research and Medical Center and the University of Colorado have completed a series of studies demonstrating that AEOL 10150 provides statistically significant protection of the lungs and skin in the 2-chloroethyl-ethylsulfide (CEES; half mustard) model of mustard gas exposure in rats. - [Read more]

HairDX, LLC (http://www.hairdx.com) pioneers of consumer-friendly genetic tests for hair loss, today introduced the first meaningful test using genetic markers strongly associated with Female Hair Loss (Female Androgenetic Alopecia). The easy to understand test provides an accurate and understandable genetic analysis of a womans likelihood of developing this common type of hair loss. - [Read more]

"Skin cancers on the scalp or neck are more deadly than those elsewhere on the body, a large study has suggested", BBC News reported. The Daily Telegraph also describes the results of a new study that examined the prognosis (chance of survival) of patients who developed a malignant melanoma on their scalp or neck. - [Read more]

The U.S. Food and Drug Administration has cleared for marketing the first device made from a new form of natural rubber latex, guayule latex. The product, the Yulex Patient Examination Glove, is derived from the guayule bush, a desert plant native to the Southwestern United States.Traditional latex gloves are made from the milky sap of a rubber tree, Hevea braziliensis. - [Read more]

"Migraine hurts skin" is the headline in the Daily Mirror. The newspaper describes the symptom of sensitive skin, called allodynia, where sufferers of migraine find combing their hair, wearing jewellery or getting dressed "excruciatingly painful". The newspaper reports that 10% of people in the UK suffer migraine. The Daily Telegraph covers the same story and suggests "two thirds of migraine sufferers reported symptoms of the condition allodynia". - [Read more]

Eczema is a distressing condition for both parents and babies - the raw, red skin is painful to see and it is difficult to stop small children from scratching it. At worst, it can mean having to wet wrap wriggly toddlers each day with bandages soaked in moisturisers. It usually starts in the first year of life and affects about 10% of infants. Although most children eventually grow out of it, about half will go on to develop another allergic condition, such as asthma or hayfever. - [Read more]

BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, announced that the U.S. Food and Drug Administration (FDA) has approved the design of a single, pivotal, Phase III clinical trial evaluating its lead product, OncoVEX(GM-CSF) in previously treated patients with metastatic melanoma. The agreement was made under the Special Protocol Assessment (SPA) procedure. - [Read more]

The Endocrine Society has released new clinical practice guidelines for the treatment of hirsutism in premenopausal women. The guidelines appear in the April issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.Hirsutism is defined medically as excessive terminal hair that appears in a male pattern in women. - [Read more]

People with scalp or neck melanomas die at nearly twice the rate of people with melanoma elsewhere on the body, including the face or ears, researchers at the University of North Carolina at Chapel Hill have found.The analysis of 51,704 melanoma cases in the U.S. confirms that survival rates differ depending on where skin cancer first appears. Those with scalp or neck melanomas die at a rate 1. - [Read more]

People with migraine are more likely to experience exacerbated skin sensitivity or pain after non-painful daily activities such as rubbing ones head, combing ones hair and wearing necklaces or earrings, compared to people with other types of headache, according to a study published in the April 22, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology. - [Read more]

Skin lesions that are about the size of a pencil eraser are more likely to be melanomas, a deadly form of skin cancer, than smaller moles, according to a new study led by NYU Langone Medical Center researchers.In a new study published in the April issue of Archives of Dermatology, the NYU researchers confirm that an important warning sign of melanoma moles that are larger than 6 millimeters, the size of a pencil eraser is still valid. - [Read more]

Activa Healthcare, the UKs market leading compression therapy company, has today (21st April 2008) been awarded with the most prestigious corporate accolade for its commitment to making groundbreaking developments in treating wound pain and venous and lymphatic disease. - [Read more]

Ina phase III trial, a new treatment for moderate to severe plaquepsoriasis has been proven safe and effective. Additionally, there isalmost a linear relationship between drug dose and response, whichsuggests that patients can be accurately dosed in order to achieve aclinical response while minimizing side effects. These results werepublished on April 18, 2008 in The Lancet. - [Read more]

Pure oxygen therapy is reputed to have many medical benefits, including saving limbs from amputation, and a QUT researcher is setting out to explore its healing properties.PhD researcher James Broadbent, from Queensland University of Technologys School of Life Sciences, is studying pure oxygen, or hyperbaric, therapys effects on chronic wounds. - [Read more]